Program
Tadalafil
Also written as “tadalafil”, “Tadalafil 20 mg” and “Cialis Tab. 5mg”.
Its studies are mostly in Erectile Dysfunction · Prostatic Hyperplasia · Hypertension, Pulmonary · Pulmonary Arterial Hypertension · Carcinoma, Non-Small-Cell Lung, led by 8 companies.
Drug pageTadalafil: every studyMany companies study it; this page follows only the 59 they lead. All 193 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Eli Lilly | 490 open or running | phase 4since May 31, 2006 | Dec 16, 2002 | none ahead |
| Chong Kun Dang Pharmaceuticalits history only | 30 open or running | phase 3since Sep 2, 2015 | Sep 15, 2014 | none ahead |
| Pfizerits history only | 20 open or running | phase 2since Sep 12, 2005 | Sep 12, 2005 | none ahead |
| Futura Medical Developmentsits history only | 10 open or running | phase 3since Jul 26, 2021 | Jul 26, 2021 | none ahead |
| Hanmi Pharmaceuticalits history only | 10 open or running | phase 1since Sep 4, 2014 | Sep 4, 2014 | none ahead |
| Lidia Larrañagaits history only | 10 open or running | phase 3since May 6, 2020 | May 6, 2020 | none ahead |
| Sanofiits history only | 10 open or running | phase 3since Jan 17, 2025 | Jan 17, 2025 | none ahead |
| Seattle Gummyits history only | 11 open or running | phase 1since Feb 17, 2021 | Feb 17, 2021 | none ahead |
Also a collaborator on its studies: Bristol-Myers Squibb, Gilead Sciences, Nippon Shinyaku and ICOS.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Eli Lilly only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 33 studies since Dec 16, 2002.
- May 5, 20102 phase 4 studies in Erectile DysfunctionNCT01122264, NCT01130532
- Jun 1, 20102 phase 3 studies in Prostatic HyperplasiaNCT01139762, NCT01152190
- Jul 8, 2010Phase 2 study in Erectile DysfunctionNCT01160289 · 410 enrolled · United States
- Aug 13, 2010Phase 1 study in Prostatic HyperplasiaNCT01183650 · 24 enrolled · Germany
- May 10, 2011Phase 4 study in Erectile DysfunctionNCT01352507 · 383 enrolled · China
- Oct 24, 2011Phase 3 study in Prostatic HyperplasiaNCT01460342 · 610 enrolled · Japan, Korea, Republic of
- Nov 30, 2011Phase 2 study in Pulmonary Arterial HypertensionNCT01484431 · 20 enrolled · United States, Canada, France and more
- Apr 1, 2013Phase 3 study in Hypertension, PulmonaryNCT01824290 · 35 enrolled · United States, Austria, Belgium and more
- May 24, 2013Phase 3 study in Muscular Dystrophy, DuchenneNCT01865084 · 331 enrolled · United States, Argentina, Belgium and more
- Sep 4, 2013Phase 3 study in Prostatic HyperplasiaNCT01937871 · 909 enrolled · China
- Jul 17, 2014Phase 2 study in Essential HypertensionNCT02194465 · 304 enrolled · United States, Canada, Puerto Rico
- Aug 20, 2014Phase 4 study in Erectile DysfunctionNCT02224846 · 635 enrolled · China
- Nov 20, 2014Phase 1 study in Healthy VolunteersNCT02300259 · 48 enrolled · United States
- Apr 28, 2015Phase 4 study in Prostatic HyperplasiaNCT02431754 · 171 enrolled · Japan
TargetBeta
“Phosphodiesterase 5A inhibitor”ChEMBL 37, by rule
Other programs on PDE5A
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| sildenafilrule | Viatris | phase 4 | 74 |
Studies
All 49 Eli Lilly leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT02431754Prostatic Hyperplasia · Japan | 4 | Completed | Feb 2016 | 171 |
| NCT02300259Healthy Volunteers · United States | 1 | Completed | Apr 2015 | 48 |
| NCT02224846Erectile Dysfunction · China | 4 | Completed | May 2016 | 635 |
| NCT02194465Essential Hypertension · United States, Canada, Puerto Rico | 2 | Completed | Mar 2015 | 304 |
| NCT01937871Prostatic Hyperplasia · China | 3 | Completed | Dec 2015 | 909 |
| NCT01865084Muscular Dystrophy, Duchenne · United States, Argentina, Belgium and more | 3 | Terminated | Dec 2015 | 331 |
| NCT01824290Hypertension, Pulmonary · United States, Austria, Belgium and more | 3 | Completed | Mar 18, 2019 | 35 |
| NCT01484431Pulmonary Arterial Hypertension · United States, Canada, France and more | 2 | Completed | Apr 21, 2017 | 20 |
| NCT01460342Prostatic Hyperplasia · Japan, Korea, Republic of | 3 | Completed | Oct 2012 | 610 |
| NCT01352507Erectile Dysfunction · China | 4 | Completed | Jun 2012 | 383 |
| NCT01183650Prostatic Hyperplasia · Germany | 1 | Completed | Apr 2011 | 24 |
| NCT01160289Erectile Dysfunction · United States | 2 | Completed | Nov 2011 | 410 |
| NCT01152190Prostatic Hyperplasia · United States, Austria, Italy | 3 | Completed | Jul 2012 | 97 |
| NCT01139762Prostatic Hyperplasia · United States, Argentina, Belgium and more | 3 | Completed | Feb 2012 | 696 |
| NCT01130532Erectile Dysfunction · United States, Canada | 4 | Completed | Jan 2012 | 623 |
| NCT01122264Erectile Dysfunction · France, Germany, Greece and more | 4 | Completed | Jun 2011 | 770 |
| NCT01026818Erectile Dysfunction · Belgium, Canada, France and more | 4 | Completed | Oct 2012 | 583 |
| NCT00970632Prostatic Hyperplasia · Australia, Austria, Belgium and more | 3 | Completed | Jan 2011 | 511 |
| NCT00861757Prostatic Hyperplasia · Japan, Taiwan | 3 | Completed | Jun 2010 | 612 |
| NCT00855582Erectile Dysfunction · United States, Canada, France and more | 3 | Completed | Jul 2010 | 606 |
| NCT00848081Prostatic Hyperplasia · United States, Puerto Rico | 3 | Completed | Dec 2009 | 318 |
| NCT00836693Erectile Dysfunction · Germany, Greece, Italy and more | 3 | Completed | Jan 2010 | 217 |
| NCT00833638Erectile Dysfunction · United States | 4 | Completed | Jun 2009 | 372 |
| NCT00827242Prostatic Hyperplasia · United States, Argentina, Germany and more | 3 | Completed | Nov 2009 | 325 |
| NCT00783094Prostatic Hyperplasia · Japan | 2 | Completed | Jun 2009 | 422 |
| NCT00734604Erectile Dysfunction · United States, Australia, Brazil and more | 3 | Completed | Sep 2009 | 378 |
| NCT00549302Hypertension, Pulmonary · United States, Belgium, Canada and more | 3 | Completed | Feb 2012 | 357 |
| NCT00547625Prostatic Hyperplasia · United States | 2 | Completed | 275 | |
| NCT00547599Erectile Dysfunction · Sweden | 4 | Completed | 659 | |
| NCT00547573Erectile Dysfunction · China | 3 | Completed | 367 | |
| NCT00547508Erectile Dysfunction · United States | 3 | Completed | 485 | |
| NCT00547495Erectile Dysfunction · Japan | 3 | Completed | 343 | |
| NCT00547417Erectile Dysfunction · United States | 3 | Completed | 1,933 | |
| NCT00547352Erectile Dysfunction · Korea, Republic of | 4 | Completed | 160 | |
| NCT00547287Erectile Dysfunction · Brazil | 3 | Completed | 2,760 | |
| NCT00547183Erectile Dysfunction · Germany | 3 | Completed | 298 | |
| NCT00547092Erectile Dysfunction · United Kingdom | 4 | Completed | 386 | |
| NCT00540124Prostatic Hyperplasia · Korea, Republic of | 2 | Completed | Jun 2008 | 151 |
| NCT00422734Erectile Dysfunction · United States, Austria, France and more | 3 | Completed | Jan 2008 | 342 |
| NCT00422578Erectile Dysfunction · Finland | 4 | Completed | 200 | |
| NCT00421083Erectile Dysfunction · United States | 3 | Completed | 180 | |
| NCT00386009Prostatic Hyperplasia · United States, Greece, Portugal | 2 | Completed | May 2008 | 200 |
| NCT00384930Prostatic Hyperplasia · United States | 3 | Completed | Oct 2007 | 1,058 |
| NCT00382135Erectile Dysfunction · United States | 4 | Completed | 282 | |
| NCT00381732Erectile Dysfunction · United States | 3 | Completed | 280 | |
| NCT00333281Erectile Dysfunction · United States | 4 | Completed | 198 | |
| NCT00157326Hypertension · United States | 2 | Completed | 180 | |
| NCT00125918Hypertension, Pulmonary · United States, France, Italy | 3 | Completed | Aug 2007 | 406 |
| NCT00050609Gastroparesis · Canada | 2 | Completed | 2 |
How it is read
Names in the registry
- “tadalafil”, 45 entries
- “Tadalafil”, 25 entries
- “Tadalafil 20 mg”, 2 entries
- “Cialis Tab. 5mg”, 2 entries
- “Tadalafil 5 mg”, 2 entries
Conditions, from the studies’ own filings
- Erectile Dysfunction, 32 studies
- Prostatic Hyperplasia, 18 studies
- Hypertension, Pulmonary, 4 studies
- Pulmonary Arterial Hypertension, 4 studies
- Carcinoma, Non-Small-Cell Lung, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.